GO and KEGG analysis identified that the action of CBX3 in PAAD may involve cell cycle regulation, and cell cycle protein CDK1 and PCNA may be the down-stream target of CBX3. This evidence concerns the gene PCNA and pancreatic adenocarcinoma.